-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/childhood-cancer-disposition-comments.pdf
February 16, 2022 - and “Discussion,
Summary of Findings).
9 Peer Reviewer #1 Discussion
and
Conclusions
in the limitations … comment.
18 Peer Reviewer #2 Discussion
and
Conclusions
I think that authors very clearly address limitations … The paragraph itself clearly describes
the Strengths and Limitations of our
literature review approach … .
45 Peer Reviewer #4 Discussion
and
Conclusions
Implications of discussions are adequate and limitations
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/childhood-cancer-disposition-comments.pdf
February 16, 2022 - and “Discussion,
Summary of Findings).
9 Peer Reviewer #1 Discussion
and
Conclusions
in the limitations … comment.
18 Peer Reviewer #2 Discussion
and
Conclusions
I think that authors very clearly address limitations … The paragraph itself clearly describes
the Strengths and Limitations of our
literature review approach … .
45 Peer Reviewer #4 Discussion
and
Conclusions
Implications of discussions are adequate and limitations
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - described in the report should
be very carefully written to reflect this narrow focus and the resulting
limitations … Each of these
limitations is significant in that they relate to treatment decisions that
physicians … We also think that the report needs to clearly
explain the limitations of any conclusions that should … However,
because of limitations of space, papers seldom describe full study
methods.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - described in the report should
be very carefully written to reflect this narrow focus and the resulting
limitations … Each of these
limitations is significant in that they relate to treatment decisions that
physicians … We also think that the report needs to clearly
explain the limitations of any conclusions that should … However,
because of limitations of space, papers seldom describe full study
methods.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Limitations of the Measure
Describe any limitations of the measure related to the attributes included … the measure should be selected for use, taking into
account a balance among desirable attributes and limitations … Limitations of the Measure
Section 13.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
December 01, 2015 - Methodological
limitations have prevented conclusive evidence synthesis
for these treatments.14-23 … of risk of bias across domains and
confidence that the results were believable given the
study’s limitations … Study
limitations included possible unmeasured or unknown
confounders. … Limitations
Current evidence has several limitations. … These limitations
further complicate the translation of reported changes
23
in sleep or global
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
December 01, 2015 - Methodological
limitations have prevented conclusive evidence synthesis
for these treatments.14-23 … of risk of bias across domains and
confidence that the results were believable given the
study’s limitations … Study
limitations included possible unmeasured or unknown
confounders. … Limitations
Current evidence has several limitations. … These limitations
further complicate the translation of reported changes
23
in sleep or global
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - estimated prevalence of 20.4 percent in U.S. adults, with 8.0 percent reporting high
impact (resulting in limitations … Methodological limitations included baseline differences
between groups and failure to control for confounding
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - estimated prevalence of 20.4 percent in U.S. adults, with 8.0 percent reporting high
impact (resulting in limitations … Methodological limitations included baseline differences
between groups and failure to control for confounding